These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 9298051

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Topical ketorolac tromethamine 0.5% versus diclofenac sodium 0.1% to inhibit miosis during cataract surgery.
    Srinivasan R, Madhavaranga.
    J Cataract Refract Surg; 2002 Mar; 28(3):517-20. PubMed ID: 11973101
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.
    Heier J, Cheetham JK, Degryse R, Dirks MS, Caldwell DR, Silverstone DE, Rosenthal A.
    Am J Ophthalmol; 1999 Mar; 127(3):253-9. PubMed ID: 10088733
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of Topical Nonsteroidal Anti-inflammatory Drugs on Pupillary Size During Uncomplicated Cataract Surgery.
    Rodríguez-García A, Hernández-Camarena JC, López-Jaime GR, Nava-García JA.
    J Refract Surg; 2017 Apr 01; 33(4):236-242. PubMed ID: 28407163
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Acular as a single agent for use as an antimiotic and anti-inflammatory in cataract surgery.
    Snyder RW, Siekert RW, Schwiegerling J, Donnenfeld E, Thompson P.
    J Cataract Refract Surg; 2000 Aug 01; 26(8):1225-7. PubMed ID: 11008052
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Preventing perioperative miosis in cataract surgery.
    Chatterjee S.
    J Cataract Refract Surg; 2003 Mar 01; 29(3):423. PubMed ID: 12662990
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients.
    Wittpenn JR, Silverstein S, Heier J, Kenyon KR, Hunkeler JD, Earl M, Acular LS for Cystoid Macular Edema (ACME) Study Group.
    Am J Ophthalmol; 2008 Oct 01; 146(4):554-560. PubMed ID: 18599019
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification: prospective randomized double-masked study.
    Holzer MP, Solomon KD, Sandoval HP, Vroman DT.
    J Cataract Refract Surg; 2002 Jan 01; 28(1):93-9. PubMed ID: 11777716
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Topical ketorolac tromethamine 0.5% ophthalmic solution in ocular inflammation after cataract surgery.
    Solomon KD, Cheetham JK, DeGryse R, Brint SF, Rosenthal A.
    Ophthalmology; 2001 Feb 01; 108(2):331-7. PubMed ID: 11158809
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of preoperative nonsteroidal anti-inflammatory drug and the re-dilation technique in minimizing miosis after femtosecond laser in cataract surgery.
    Ventura BV, Rabello LP, Silvestre F, Ventura MC.
    Arq Bras Oftalmol; 2019 Feb 01; 82(2):111-118. PubMed ID: 30698231
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.